MYC and triple-negative breast carcinoma: MYC amplification occurs in ~25% of all breast cancers and occurs more frequently in triple negative breast cancer (TNBC) (up to 50%).4,5 MYC gene amplification is associated with risk of relapse, poor prognosis, and death.6,7